Skip to main content
OpenTrials

Clinical trial condition

Overactive Bladder

Explore clinical trials studying Overactive Bladder. Study availability and eligibility vary by location and protocol.

363 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Overactive Bladder trial results

Completed

A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder

NCT02045862

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +15 more
Locations
  • Site US10049 Mobile, Alabama, United States
  • Site US10112 Mobile, Alabama, United States
  • Site US10104 Chandler, Arizona, United States
  • Site US10021 Phoenix, Arizona, United States
View all 251 locations
View Trial Details
Completed

A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice

NCT02320773

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Site CZ42009 UROMEDA s. r. o. Brno, Czechia
  • Site CZ42003 Fakultni nemocnice Brno-Bohunice Brno, Czechia
  • Site CZ42006 Hospital Kyjov Kyjov, Czechia
  • Site CZ42002 Fakultni nemocnice Kralovske Vinohrady Prague, Czechia
View all 60 locations
View Trial Details
Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

NCT02526979

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Site DK45002 Aalborg, Denmark
  • Site DK45001 Aarhus, Denmark
  • Site PL48001 Warsaw, Poland
View Trial Details
Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder

NCT02211846

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Site BE32009 Univ.Ziekenhuis Antwerpen Edegem, Belgium
  • Site BE32003 Gent University Hospital Ghent, Belgium
  • Site BE32004 AZ Groeninge, Campus Vercruyss Kortrijk, Belgium
  • Site BE32011 U.Z. Leuven Leuven, Belgium
View all 13 locations
View Trial Details
Completed

A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)

NCT02386072

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Site US1051 Birmingham, Alabama, United States
  • Site US1094 Birmingham, Alabama, United States
  • Site US1010 Huntsville, Alabama, United States
  • Site US1020 Mobile, Alabama, United States
View all 92 locations
View Trial Details
Completed

Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease

NCT03149809

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +21 more
Locations
  • Birmingham VA Medical Center, Birmingham, AL Birmingham, Alabama, United States
  • Atlanta VA Medical and Rehab Center, Decatur, GA Decatur, Georgia, United States
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA Philadelphia, Pennsylvania, United States
  • Hunter Holmes McGuire VA Medical Center, Richmond, VA Richmond, Virginia, United States
View Trial Details
Completed

Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia

NCT04103450

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +13 more
Locations
  • Private Practice Huntsville, Alabama, United States
  • Clinical Trials Research Lincoln, California, United States
  • American Institute of Research Los Angeles, California, United States
  • Tri Valley Urology Medical Group Murrieta, California, United States
View all 35 locations
View Trial Details

Related conditions